(ATN) PCR Test Cautions

DonateNow
Print this article

(ATN) PCR Test Cautions

AIDS TREATMENT NEWS No. 062 - August 12, 1988
John S. James


Issue #60 of AIDS Treatment News described the new PCR test, a very sensitive biochemical test for HIV. After reading the article, Joseph Sonnabend, M. D. called to alert us to the con- troversy over whether this research test is ready for clinical diagnostic use, because of the unknown risk that it could produce false positives or false negatives. Dr. Sonnabend and others, some speaking off the record, alerted us to the following information and concerns:

* The PCR test is so sensitive that sometimes it can detect a single molecule of the DNA being looked for. Therefore it is also extremely sensitive to even the tiniest contamination of laboratory glassware, reagents, etc.

* Even small variations in the chemicals used in the test can cause large differences in the result. And no one has yet made sure that the test works in a standard way when performed in different laboratories.

* Although about 200 people at least have already been tested with the PCR, this number is too small to provide very accurate data on the risk of false positives or false negatives.

* It is too early to be sure of the clinical meaning of a PCR test.

Most experts seem to agree (1) that the PCR should not be used by itself for diagnosing patients, and that (2) this very important research test may also be useful for diagnosis after more is known about it. Whether the PCR should be used at all at this time for diagnosing patients remains controversial.


880812
ATN06204


Copyright © 1988 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org  http://www.aidsnews.org

Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .